Demo Sign up Log In

Vertex Pharmaceuticals (VRTX)

Interest Expense

$6.60M

TTM · Period ending: Jun 30, 2026 · USD

VRTX Interest Expense

Latest reported$6.60Mperiod endingJun 30, 2026

Latest reported$6.60Mperiod endingJun 30, 2026

VRTX Interest Expense ($0.00 → $6.60M)

Annual interest expense

High-resolution chart · PNG

VRTX interest expense history

Annual fiscal periods · USD. Dates are reporting period ends; fiscal years can differ from calendar years.

Vertex Pharmaceuticals Interest Expense — Annual fiscal periods (USD)
Period ending	Interest Expense (USD)
Dec 31, 2025	13,300,000
Dec 31, 2024	30,600,000
Dec 31, 2023	44,100,000
Dec 31, 2022	54,800,000
Dec 31, 2021	61,500,000
Dec 31, 2020	58,151,000
Dec 31, 2019	58,502,000
Dec 31, 2018	34,119,000
Dec 31, 2017	69,298,000
Dec 31, 2016	81,432,000
Dec 31, 2015	84,206,000
Dec 31, 2014	72,863,000
Dec 31, 2013	22,730,000
Dec 31, 2012	16,652,999
Dec 31, 2011	36,574,000
Dec 31, 2010	19,275,000
Dec 31, 2009	13,192,000
Dec 31, 2008	13,471,000
Dec 31, 2007	0
Dec 31, 2006	0
Dec 31, 2005	0
Dec 31, 2004	0
Dec 31, 2003	0
Dec 31, 2002	0
Dec 31, 2001	0
Dec 31, 2000	0
Dec 31, 1999	0
Dec 31, 1998	0
Dec 31, 1997	0
Dec 31, 1996	0
Dec 31, 1995	0
Dec 31, 1994	0
Dec 31, 1993	0
Dec 31, 1992	0
Dec 31, 1991	0
Dec 31, 1990	0

Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.